Davern Capital Partners, LP 13F Portfolio

EntityCategoryQoQ AUM ChangeAUM (13F)# of HoldingsPerformance RankEquities Trend
DC
Davern Capital Partners, LP
Institutional Filer 17.86%$364.5M17

Current Portfolio Holdings

Showing all 17 reported positions by value

#StockCompany NameSectorShares HeldMarket Value% of Portfolio
1PFEPfizer Inc.Healthcare1.6M$44.8M12.28%
2REGNRegeneron Pharmaceuticals, Inc.Healthcare45K$34.6M9.50%
3INSMInsmed IncorporatedHealthcare183K$29.9M8.19%
4IONSIonis Pharmaceuticals, Inc.Healthcare387K$29.1M7.97%
5NTRANatera, Inc.Healthcare144K$28.8M7.90%
6BNTXBioNTech SEHealthcare305K$27.1M7.44%
7ARGXargenx SEHealthcare35K$25.6M7.02%
8LLYEli Lilly and CompanyHealthcare27K$25.1M6.88%
9RPRXRoyalty Pharma plcHealthcare520K$24.9M6.84%
10ROIVRoivant Sciences Ltd.Healthcare873K$24.2M6.64%
11LEGNLegend Biotech CorporationHealthcare1.3M$23.8M6.52%
12MLYSMineralys Therapeutics, Inc.Healthcare447K$12.1M3.32%
13ABVXAbivax S.A.Healthcare78K$8.7M2.39%
14NaNGENERATE BIOMEDICINES INC592K$7.4M2.03%
15PRCTPROCEPT BioRobotics CorporationHealthcare261K$6.5M1.79%
Showing 1 to 15 of 17 holdings